| Literature DB >> 15295768 |
Peter A Lim1, Yee Sien Ng, Boon Keng Tay.
Abstract
Severe acute respiratory syndrome (SARS) is a new respiratory viral epidemic that originated in China but has affected many parts of the world, with devastating impact on economies and the practice of medicine and rehabilitation. A novel coronavirus has been implicated, with transmission through respiratory droplets. Rehabilitation was significantly affected by SARS, because strict infection control measures run counter to principles such as multidisciplinary interactions, patients encouraging and learning from each other, and close physical contact during therapy. Immunocompromised patients who may silently carry SARS are common in rehabilitation and include those with renal failure, diabetes, and cancer. Routine procedures such as management of feces and respiratory secretions (eg, airway suctioning, tracheotomy care) have been classified as high risk. Personal protection equipment presented not only a physical but also a psychologic barrier to therapeutic human contact. Visitor restriction to decrease chances of disease transmission are particularly difficult for long-staying rehabilitation patients. At the height of the epidemic, curtailment of patient movement stopped all transfers for rehabilitation, and physiatrists had to function as general internists. Our experiences strongly suggest that rehabilitation institutions should have emergency preparedness plans because such epidemics may recur, whether as a result of nature or of bioterrorism.Entities:
Mesh:
Year: 2004 PMID: 15295768 PMCID: PMC7124386 DOI: 10.1016/j.apmr.2004.01.022
Source DB: PubMed Journal: Arch Phys Med Rehabil ISSN: 0003-9993 Impact factor: 3.966
DEFINITIONS FOR SURVEILLANCE OF SARS AND LABORATORY METHODS FOR SARS DIAGNOSIS
| Case Definitions for Surveillance of SARS | |
|---|---|
| Suspect case | 1. Presenting after 1 November 2002 with history of: |
| High fever (>38°C) | |
| and | |
| Cough or difficulty breathing | |
| and | |
| Close contact with suspect or probable case of SARS, and/or | |
| Travel history to area with recent local SARS transmission, and/or | |
| Residing in area with recent local SARS transmission | |
| 2. Unexplained acute respiratory illness resulting in death after 1 November 2002, without autopsy | |
| and | |
| Close contact with suspect or probable case of SARS, and/or | |
| Travel history to area with recent local SARS transmission, and/or | |
| Residing in area with recent local SARS transmission | |
| Probable case | 1. Suspect case with infiltrates consistent with pneumonia or respiratory distress syndrome (RDS) on chest x-ray |
| 2. Suspect case positive for SARS coronavirus by 1 or more assays | |
| 3. Suspect case with autopsy findings consistent with RDS without identifiable cause | |
| Use of Laboratory Methods for SARS Diagnosis | |
| Positive SARS diagnostic test | a) Confirmed positive PCR for SARS virus |
| At least 2 different clinical specimens (eg, nasopharyngeal and stool), or | |
| Same clinical specimen collected on 2 or more days during illness (eg, 2 or more nasopharyngeal aspirates), or | |
| Two different assays or repeat PCR using original clinical sample on each occasion | |
| b) Seroconversion by ELISA or IFA | |
| Negative antibody test on acute serum followed by positive antibody test on convalescent serum, or | |
| Four-fold or greater rise in antibody titer between acute and convalescent phase sera tested in parallel | |
| c) Virus isolation | |
| Isolation in cell culture of SARS CoV from any specimen, plus PCR confirmation using validated method | |
NOTE. Adapted by permission of the World Health Organization.13, 14
Abbreviations: CoV, coronavirus; ELISA, enzyme-linked immunosorbent assay; IFA, immunofluorescent assay.